Blockade of high mobility group box 1 augments antitumor T-cell response induced by peptide vaccination as a co-adjuvant.

Cancer Sci · 2016 · PMC5198958 · PMID 27717108

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As shown in Figure 3 , gabexate mesilate and nafamostat significantly enhanced OVA 257–264 ‐induced OT‐1 CD8 T‐cell proliferation, and sivelestat also showed a trend toward enhancement, although this effect was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.